Tema ETFs capitalized on risk appetite for weight loss stocks. It’s behind the GLP-1, obesity and cardiometabolic ETF (HRTS)which is up 26% since its launch last...
Global obesity rates have almost tripled since 1975 and are expected to affect more than half the population by 2035, according to the WHO and Goldman...
Global obesity rates have almost tripled since 1975 and are expected to affect more than half the population by 2035, according to the WHO and Goldman...
Company continues advancing the development of miniature, long-term GLP-1 implants for the treatment of chronic weight management in obese or overweight patients, type 2 diabetes, and...
